| Gene: | LCK |
| GeneID: | ENSG00000182866 |
| Chrom: | 1 |
| Start position: | 32251244 |
| End position: | 32286165 |
| Pathway: | Natural killer cell mediated cytotoxicity |
| Class: | Organismal Systems; Immune system |
| FST gene level: | 0.0854311 |
| Number of nsSNPs: | 1 |
| nsSNPs in gene: | rs145088108 |
| Gene Structure: |  |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Expression restricted in 2 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 1500.26 (Percentile rank: 97.05%) |
| PubTator score: | 874.30 (Percentile rank: 95.94%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |
